Terms: = Leukemia AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
244 results:
1. Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines.
Rajabinejad M; Valadan R; Tehrani M; Najafi A; Negarandeh R; Saeedi M; Asgarian-Omran H
Med Oncol; 2024 May; 41(6):149. PubMed ID: 38739199
[TBL] [Abstract] [Full Text] [Related]
2. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid leukemia.
Ureshino H; Kamachi K; Kimura S
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e138-e141. PubMed ID: 38195325
[TBL] [Abstract] [Full Text] [Related]
3. Dual role of Nrf2/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells.
Chen Z; Zhu Q; Qi X; Yang LR; Rong YX; Wei Q; Wu SQ; Lu QW; Li L; Jiang MD; Qi H
Phytomedicine; 2024 Feb; 124():155288. PubMed ID: 38183698
[TBL] [Abstract] [Full Text] [Related]
4. System analysis of surface CD markers during the process of granulocytic differentiation.
Novikova SE; Tolstova TV; Soloveva NA; Farafonova TE; Tikhonova OV; Kurbatov LK; Rusanov AL; Zgoda VG
Biomed Khim; 2023 Dec; 69(6):383-393. PubMed ID: 38153053
[TBL] [Abstract] [Full Text] [Related]
5. Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Perusini MA; Novitzky-Basso I; Atenafu EG; Forrest D; Bence-Bruckler I; Savoie L; Keating MM; Busque L; Delage R; Xenocostas A; Liew E; Laneuville P; Paulson K; Stockley T; Lipton JH; Leber B; Kim DDH
Br J Haematol; 2023 Dec; 203(5):781-791. PubMed ID: 37697469
[TBL] [Abstract] [Full Text] [Related]
6. CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Bauer K; Machherndl-Spandl S; Kazianka L; Sadovnik I; Gültekin S; Suessner S; Proell J; Lauf J; Hoermann G; Eisenwort G; Häfner N; Födermayr-Mayrleitner M; Schmolke AS; van der Kouwe E; Platzbecker U; Lion T; Weltermann A; Zach O; Webersinke G; Germing U; Gabriel C; Sperr WR; Béné MC; Staber PB; Bettelheim P; Valent P
Leukemia; 2023 Nov; 37(11):2250-2260. PubMed ID: 37673973
[TBL] [Abstract] [Full Text] [Related]
7. The role of cadmium in the pathogenesis of myeloid leukemia in individuals with anemia, deficiencies in vitamin D, zinc, and low calcium dietary intake.
Djulejic V; Petrovic B; Jevtic J; Vujacic M; Clarke BL; Cirovic A; Cirovic A
J Trace Elem Med Biol; 2023 Sep; 79():127263. PubMed ID: 37499549
[TBL] [Abstract] [Full Text] [Related]
8. Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia.
Tian C; Zheng M; Lan X; Liu L; Ye Z; Li C
Gene; 2023 Aug; 879():147597. PubMed ID: 37390872
[TBL] [Abstract] [Full Text] [Related]
9. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
[TBL] [Abstract] [Full Text] [Related]
10. A Case of AML1-ETO Positive Acute Myeloid leukemia Morphologically Similar to Chronic Myelogenous leukemia.
Li R; Wu Y; Zhang X; LihuaWang ; Huo S
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145071
[TBL] [Abstract] [Full Text] [Related]
11. A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid leukemia (CML): Can it be Applied in Clinical Practice?
Çiftçiler R; Akın MG; Erat Z; Eşkazan AE
Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):8-14. PubMed ID: 36344420
[TBL] [Abstract] [Full Text] [Related]
12. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.
Fang H; Wang SA; You MJ; Hu S; Miranda RN; Tang Z; Lin P; Jorgensen JL; Xu J; Thakral B; Schlette EJ; El Hussein S; Bueso-Ramos C; Medeiros LJ; Wang W
Cytometry B Clin Cytom; 2022 Nov; 102(6):440-447. PubMed ID: 36156384
[TBL] [Abstract] [Full Text] [Related]
13. Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Plett C; Klauer LK; Amberger DC; Ugur S; Rabe A; Fischer Z; Deen D; Hirn-Lopez A; Gunsilius C; Werner JO; Schmohl J; Krämer D; Rank A; Schmid C; Schmetzer HM
Clin Immunol; 2022 Sep; 242():109083. PubMed ID: 35908638
[TBL] [Abstract] [Full Text] [Related]
14. Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia.
Kim E; Hwang EJ; Lee J; Kim DY; Kim JY; Kim DW
Neoplasia; 2022 Oct; 32():100817. PubMed ID: 35878453
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy Manufacturing.
Cheng EL; Cardle II; Kacherovsky N; Bansia H; Wang T; Zhou Y; Raman J; Yen A; Gutierrez D; Salipante SJ; des Georges A; Jensen MC; Pun SH
J Am Chem Soc; 2022 Aug; 144(30):13851-13864. PubMed ID: 35875870
[TBL] [Abstract] [Full Text] [Related]
16. Identification of differentially expressed genes and pathways in diquat and paraquat poisoning using bioinformatics analysis.
Miao C; Fan D
Toxicol Mech Methods; 2022 Nov; 32(9):678-685. PubMed ID: 35392760
[TBL] [Abstract] [Full Text] [Related]
17. ETV6 Regulates Hemin-Induced Erythroid Differentiation of K562 Cells through Mediating the Raf/MEK/ERK Pathway.
Li Z; Sun MZ; Lv X; Guo C; Liu S
Biol Pharm Bull; 2022; 45(3):250-259. PubMed ID: 35228392
[TBL] [Abstract] [Full Text] [Related]
18. Iron deficiency as promoter of heavy metals-induced acute myeloid leukemia.
Cirovic A; Cirovic A
Leuk Res; 2022 Jan; 112():106755. PubMed ID: 34844140
[TBL] [Abstract] [Full Text] [Related]
19. Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects.
Wang C; Zhang W; He Y; Gao Z; Liu L; Yu S; Hu Y; Wang S; Zhao C; Li H; Shi J; Zhou W; Li F; Yue H; Li Y; Wei W; Ma G; Ma D
Nat Nanotechnol; 2021 Dec; 16(12):1413-1423. PubMed ID: 34697490
[TBL] [Abstract] [Full Text] [Related]
20. Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis.
Zou J; Shi Q; Chen H; Juskevicius R; Zinkel SS
Exp Hematol; 2021 Nov; 103():60-72.e5. PubMed ID: 34563605
[TBL] [Abstract] [Full Text] [Related]
[Next]
